Complications of post-chemotherapy retroperitoneal lymph node dissection
- PMID: 7853586
Complications of post-chemotherapy retroperitoneal lymph node dissection
Abstract
The surgical morbidity rate of 603 patients who underwent lymphadenectomy after primary chemotherapy for clinical stages II and III testis cancer from 1982 to 1992 was reviewed. There were 144 complications in 125 patients (20.7%). The majority of patients (93%) had a tumor volume of greater than 5 cm. Five patients died 3 to 47 days postoperatively, for an operative mortality rate of 0.8%. Pulmonary complications were the most frequent cause of severe morbidity: 6 patients had the adult respiratory distress syndrome and 5 needed prolonged ventilation. The underlying cause was a combination of bleomycin induced pulmonary toxicity, and large volume retroperitoneal and pulmonary disease resected in these patients. Limiting inspired oxygen concentration and perioperative volume replacement are imperative to minimize bleomycin related pulmonary morbidity. Additional procedures, such as nephrectomy and colectomy, did not add to the morbidity rate. Among patients undergoing concomitant venacavectomy there was a higher occurrence of postoperative chylous ascites. Most of the other complications (gastrointestinal, lymphatic, neurological and renal) were temporary and treated conservatively. Perioperative management of the post-chemotherapy testis cancer patient is different from that of the patient undergoing primary retroperitoneal lymphadenectomy. The latter operation is usually performed in physically fit patients and the surgical template of dissection is of a smaller scale. Thus, the complications in this group are minor and without mortality. Specific technical considerations and difficulties are common to post-chemotherapy patients. Factors, such as large volume of disease, post-chemotherapy desmoplastic reaction and extensive retroperitoneal dissection, make these patients more prone to have complications. Decreased pulmonary, renal and nutritional reserves add to the surgical morbidity. Knowledge of possible pitfalls and their causes can avoid unnecessary operative complications.
Similar articles
-
Complications of primary retroperitoneal lymph node dissection.J Urol. 1994 Aug;152(2 Pt 1):424-7. J Urol. 1994. PMID: 8015086
-
Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.J Urol. 2003 May;169(5):1710-4. doi: 10.1097/01.ju.0000060960.18092.54. J Urol. 2003. PMID: 12686815
-
Repeat retroperitoneal lymph node dissection for metastatic testis cancer.J Urol. 2003 Apr;169(4):1353-6. doi: 10.1097/01.ju.0000052372.06901.de. J Urol. 2003. PMID: 12629359
-
Complications of retroperitoneal lymph node dissection in testicular cancer: primary and post-chemotherapy.Semin Surg Oncol. 1999 Dec;17(4):263-7. doi: 10.1002/(sici)1098-2388(199912)17:4<263::aid-ssu7>3.0.co;2-6. Semin Surg Oncol. 1999. PMID: 10588855 Review.
-
Long-term outcome of retroperitoneal lymph node dissection in the management of testis cancer.World J Urol. 2006 Aug;24(3):267-72. doi: 10.1007/s00345-006-0060-8. Epub 2006 Mar 8. World J Urol. 2006. PMID: 16523338 Review.
Cited by
-
Post-chemotherapy robot-assisted retroperitoneal lymph node dissection in non-seminomatous germ cell tumor of testis: Feasibility and outcomes of initial cases.Turk J Urol. 2018 Dec 20;45(2):113-117. doi: 10.5152/tud.2018.99390. Print 2019 Mar. Turk J Urol. 2018. PMID: 30875289 Free PMC article.
-
Post-chemotherapy retroperitoneal lymph node dissection for non-seminomatous germ cell tumors: A single-surgeon, Canadian experience.Can Urol Assoc J. 2020 Sep;14(9):E407-E411. doi: 10.5489/cuaj.6219. Can Urol Assoc J. 2020. PMID: 32223881 Free PMC article.
-
Characterizing the Morbidity of Postchemotherapy Retroperitoneal Lymph Node Dissection for Testis Cancer in a National Cohort of Privately Insured Patients.Urology. 2016 May;91:70-6. doi: 10.1016/j.urology.2016.01.010. Epub 2016 Jan 21. Urology. 2016. PMID: 26802801 Free PMC article.
-
Outcomes following retroperitoneal lymph node dissection in postchemotherapy residual masses in advanced testicular germ cell tumors.Indian J Urol. 2016 Jan-Mar;32(1):40-4. doi: 10.4103/0970-1591.173102. Indian J Urol. 2016. PMID: 26941493 Free PMC article.
-
Secondary surgery in germ cell tumors--when and how extensively should it be performed?World J Urol. 2004 Apr;22(1):37-40. doi: 10.1007/s00345-004-0402-3. Epub 2004 Mar 30. World J Urol. 2004. PMID: 15052501 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical